Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tracking Inflammatory Cells Using Superparamagnetic Particles of Iron Oxide (SPIO) and Magnetic Resonance Imaging (MRI)

This study has been completed.
Sponsor:
Collaborators:
Translational Medicine Research Collaboration
British Heart Foundation
Information provided by (Responsible Party):
University of Edinburgh
ClinicalTrials.gov Identifier:
NCT01169935
First received: July 23, 2010
Last updated: February 4, 2013
Last verified: February 2013